News

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Drug Development Is Slowing Down After Cuts at the FDA
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
Fierce Biotech12h
FDA clears its first prescription migraine app, from Click Therapeutics
Click Therapeutics has collected a groundbreaking green light from the FDA for the agency’s first prescription digital ...
FDA to phase out some animal testing requirements, possibly replace them with AI models
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
Cancer Therapy Advisor3d
FDA Roundup: Oncology Drug Approvals in 2025
On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...
US FDA to phase out animal testing in drug development
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
Dermatology Advisor1d
FDA Drug Approval Decisions Expected in May 2025
Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.
To promote drug safety, FDA to replace animal testing with AI-based experiments, other methods
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...